{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:33:17Z","timestamp":1760189597793,"version":"3.41.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T00:00:00Z","timestamp":1515715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T00:00:00Z","timestamp":1515715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>IFNL3 is the strongest predictor of spontaneous resolution (SR) of hepatitis C virus (HCV), however, consideration of IFNL3 genotype alone is of limited clinical value for the prediction of SR or chronic HCV infection. The objective of this study was to analyze the impact of HLA-B, HLA-C and KIRs on SR, as well as their additive effects on the predictive value of the IFNL3 genotype. We conducted a retrospective study of HIV patients that included both SR and chronic HCV patients. In our study, 61.6% of patients with IFNL3 CC achieved SR, and 81.5% with non-CC genotypes did not achieve SR. HLA-B*44, HLA-C*12, and KIR3DS1 were identified as predictive factors for SR, with percentages of 77.4%, 85.7% and 86.2%, respectively, for patients who did not experience SR. The presence of at least one of these three markers, defined as a genetically unfavorable profile (GUP), combined with the IFNL3 non-CC genotype showed a value of 100% for non-SR. The absence of the three markers, defined as a genetically favorable profile (GFP), in addition to the IFNL3 CC genotype showed a percentage of 74.1% for SR. The combination of these markers in addition to the IFNL3 genotype improves the predictive value of IFNL3 for SR of acute HCV infection in HIV patients, which would be clinically valuable.<\/jats:p>","DOI":"10.1038\/s41598-017-17531-7","type":"journal-article","created":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T14:59:00Z","timestamp":1515423540000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["HLA-B, HLA-C and KIR improve the predictive value of IFNL3 for Hepatitis C spontaneous clearance"],"prefix":"10.1038","volume":"8","author":[{"given":"Mario","family":"Frias","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Rivero-Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Rodriguez-Cano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngela","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"L\u00f3pez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda \u00c1ngeles","family":"Risalde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e1rbara","family":"Manzanares-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Brieva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Machuca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Rivero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,12]]},"reference":[{"key":"17531_CR1","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1002\/hep.1840360706","volume":"36","author":"LB Seeff","year":"2002","unstructured":"Seeff, L. B. Natural history of chronic hepatitis C. Hepatology 36, S35\u201346 (2002).","journal-title":"Hepatology"},{"key":"17531_CR2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","volume":"13","author":"JM Micallef","year":"2006","unstructured":"Micallef, J. M., Kaldor, J. M. & Dore, G. J. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J. Viral Hepat. 13, 34\u201341 (2006).","journal-title":"J. Viral Hepat."},{"key":"17531_CR3","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nature08463","volume":"461","author":"DL Thomas","year":"2009","unstructured":"Thomas, D. L. et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461, 798\u2013801 (2009).","journal-title":"Nature"},{"key":"17531_CR4","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1053\/j.gastro.2010.02.033","volume":"138","author":"HL Tillmann","year":"2010","unstructured":"Tillmann, H. L. et al. A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice. Gastroenterology 138, 1240\u20131243 (2010).","journal-title":"Gastroenterology"},{"key":"17531_CR5","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1053\/j.gastro.2011.04.005","volume":"141","author":"S Knapp","year":"2011","unstructured":"Knapp, S. et al. A polymorphism in IL28B distinguishes exposed, uninfected individuals from spontaneous resolvers of HCV infection. Gastroenterology 141, 320\u2013325 (2011).","journal-title":"Gastroenterology"},{"key":"17531_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nrgastro.2013.7","volume":"10","author":"K Ray","year":"2013","unstructured":"Ray, K. Hepatitis: New gene IFNL4 is associated with impaired clearance of HCV. Nat. Rev. Gastroenterol. Hepatol. 10, 63 (2013).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"17531_CR7","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1097\/01.aids.0000433234.78807.54","volume":"27","author":"B Kr\u00e4mer","year":"2013","unstructured":"Kr\u00e4mer, B. et al. Variation in IFNL4 genotype and response to interferon-based therapy of hepatitis C in HIV-positive patients with acute and chronic hepatitis C. AIDS 27, 2817\u20132819 (2013).","journal-title":"AIDS"},{"key":"17531_CR8","unstructured":"Recommendations for Testing, Managing, and Treating Hepatitis C of the American Association for The Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA). Available at http:\/\/www.hcvguidelines.org (last accessed July 20th 2017)."},{"key":"17531_CR9","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1084\/jem.20050499","volume":"201","author":"S Rajagopalan","year":"2005","unstructured":"Rajagopalan, S. & Long, E. O. Understanding how combinations of HLA and KIR genes influence disease. J. Exp. Med. 201, 1025\u20131029 (2005).","journal-title":"J. Exp. Med."},{"key":"17531_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2007.03424.x","volume":"149","author":"RJ Boyton","year":"2007","unstructured":"Boyton, R. J. & Altmann, D. M. Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease. Clin. Exp. Immunol. 149, 1\u20138 (2007).","journal-title":"Clin. Exp. Immunol."},{"key":"17531_CR11","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3389\/fimmu.2014.00184","volume":"5","author":"MA Ivarsson","year":"2014","unstructured":"Ivarsson, M. A., Micha\u00eblsson, J. & Fauriat, C. Activating killer cell Ig-like receptors in health and disease. Front. Immunol. 5, 184 (2014).","journal-title":"Front. Immunol."},{"key":"17531_CR12","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1126\/science.1097670","volume":"305","author":"SI Khakoo","year":"2004","unstructured":"Khakoo, S. I. et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305, 872\u2013874 (2004).","journal-title":"Science"},{"key":"17531_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13401","author":"E Gauthiez","year":"2017","unstructured":"Gauthiez, E. et al. A Systematic Review and Meta-Analysis of HCV Clearance. Liver Int., https:\/\/doi.org\/10.1111\/liv.13401 (2017).","journal-title":"Liver Int"},{"key":"17531_CR14","first-page":"106","volume":"6","author":"CM Gardiner","year":"2015","unstructured":"Gardiner, C. M. NK cell function and receptor diversity in the context of HCVinfection. Front. Microbiol. 6, 106 (2015).","journal-title":"Front. Microbiol."},{"key":"17531_CR15","doi-asserted-by":"publisher","first-page":"5736","DOI":"10.1073\/pnas.1016358108","volume":"108","author":"MM Dring","year":"2011","unstructured":"Dring, M. M. et al. Innate immune genes synergize to predict increased risk of chronic disease in hepatitis C virus infection. Proc. Natl. Acad. Sci. USA 108, 5736\u20135741 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"17531_CR16","doi-asserted-by":"publisher","first-page":"e0117420","DOI":"10.1371\/journal.pone.0117420","volume":"10","author":"RV De","year":"2015","unstructured":"De, R. V. et al. Genetic diversity of the KIR\/HLA system and susceptibility to hepatitis C virus-related diseases. PLoS One 10, e0117420 (2015).","journal-title":"PLoS One"},{"key":"17531_CR17","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/hep.20261","volume":"40","author":"SM McKiernan","year":"2004","unstructured":"McKiernan, S. M. et al. Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source. Hepatology 40, 108\u2013114 (2004).","journal-title":"Hepatology"},{"key":"17531_CR18","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1136\/gutjnl-2013-306287","volume":"64","author":"K Fitzmaurice","year":"2015","unstructured":"Fitzmaurice, K. et al. Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection. Gut 64, 813\u2013819 (2015).","journal-title":"Gut"},{"key":"17531_CR19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/hep.23275","volume":"51","author":"C Neumann-Haefelin","year":"2010","unstructured":"Neumann-Haefelin, C. et al. Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8+ T-cell epitope. Hepatology 51, 54\u201362 (2010).","journal-title":"Hepatology"},{"key":"17531_CR20","doi-asserted-by":"publisher","first-page":"4792","DOI":"10.1128\/JVI.76.10.4792-4797.2002","volume":"76","author":"CL Thio","year":"2002","unstructured":"Thio, C. L. et al. HLA-Cw*04 and hepatitis C virus persistence. J. Virol. 76, 4792\u20134797 (2002).","journal-title":"J. Virol."},{"key":"17531_CR21","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1053\/j.gastro.2010.09.042","volume":"140","author":"AY Kim","year":"2011","unstructured":"Kim, A. Y. et al. Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes. Gastroenterology 140, 686\u2013696 (2011).","journal-title":"Gastroenterology"},{"key":"17531_CR22","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1097\/01.aids.0000433242.86362.21","volume":"27","author":"AK Asher","year":"2013","unstructured":"Asher, A. K. et al. Human leukocyte antigen B*57 does not fully explain hepatitis C clearance in HIV controllers. AIDS 27, 2691\u20132696 (2013).","journal-title":"AIDS"},{"key":"17531_CR23","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.humimm.2004.05.001","volume":"65","author":"LJ Fanning","year":"2004","unstructured":"Fanning, L. J., Kenny-Walsh, E. & Shanahan, F. Persistence of hepatitis C virus in a white population: associations with human leukocyte antigen class 1. Hum. Immunol. 65, 745\u2013751 (2004).","journal-title":"Hum. Immunol."},{"key":"17531_CR24","doi-asserted-by":"publisher","first-page":"e0172527","DOI":"10.1371\/journal.pone.0172527","volume":"12","author":"A Ruiz-Extremera","year":"2017","unstructured":"Ruiz-Extremera, A. et al. Influence of HLA class I, HLA class II and KIRs on vertical transmission and chronicity of hepatitis C virus in children. PLoS One 12, e0172527 (2017).","journal-title":"PLoS One"},{"key":"17531_CR25","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.3851\/IMP1913","volume":"16","author":"A Mangia","year":"2011","unstructured":"Mangia, A. et al. IL28B CC-genotype association with HLA-DQB1*0301 allele increases the prediction of spontaneous HCV RNA clearance in thalassaemic HCV-infected patients. Antivir Ther. 16, 1309\u20131316 (2011).","journal-title":"Antivir Ther."},{"key":"17531_CR26","doi-asserted-by":"publisher","first-page":"235","DOI":"10.7326\/0003-4819-158-4-201302190-00003","volume":"158","author":"P Duggal","year":"2013","unstructured":"Duggal, P. et al. Genome wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts. Ann. Intern. Med. 158, 235\u2013245 (2013).","journal-title":"Ann. Intern. Med."},{"key":"17531_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/srep31485","volume":"6","author":"J Huang","year":"2016","unstructured":"Huang, J. et al. The Associations of HLA-A*02:01 and DRB1*11:01 with Hepatitis C Virus Spontaneous Clearance Are Independent of IL28B in the Chinese Population. Sci Rep. 6, 31485 (2016).","journal-title":"Sci Rep."},{"key":"17531_CR28","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S1473-3099(13)70059-8","volume":"13","author":"K Deterding","year":"2013","unstructured":"Deterding, K. et al. Delayed versus immediate treatment for patients with acute hepatitis C: a randomised controlled non-inferiority trial. Lancet Infect. Dis. 13, 497\u2013506 (2013).","journal-title":"Lancet Infect. Dis."},{"key":"17531_CR29","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/jmv.20103","volume":"73","author":"M Lehmann","year":"2004","unstructured":"Lehmann, M. et al. High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection. J Med Virol. 73, 387\u201391 (2004).","journal-title":"J Med Virol."},{"key":"17531_CR30","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jhep.2016.04.030","volume":"65","author":"N Bulteel","year":"2016","unstructured":"Bulteel, N., Partha Sarathy, P., Forrest, E., Stanley, A. J., Innes, H. & Mills, P. R. et al. Factors associated with spontaneous clearance of chronic hepatitis C virus infection. J Hepatol. 65, 266\u201372 (2016).","journal-title":"J Hepatol."},{"key":"17531_CR31","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1034\/j.1399-0039.2002.590302.x","volume":"59","author":"N G\u00f3mez-Lozano","year":"2002","unstructured":"G\u00f3mez-Lozano, N. & Vilches, C. Genotyping of human killer-cell immunoglobulin-like receptor genes by polymerase chain reaction with sequence-specific primers: an update. Tissue Antigens 59, 184\u2013193 (2002).","journal-title":"Tissue Antigens"},{"key":"17531_CR32","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.4049\/jimmunol.161.3.1406","volume":"161","author":"S Turner","year":"1998","unstructured":"Turner, S. et al. Sequence-based typing provides a new look at HLA-C diversity. J. Immunol. 161, 1406\u20131413 (1998).","journal-title":"J. Immunol."},{"key":"17531_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/0003-4819-138-1-200301070-00012-w1","volume":"138","author":"PM Bossuyt","year":"2003","unstructured":"Bossuyt, P. M. et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann. Intern. Med. 138, 1\u201312 (2003).","journal-title":"Ann. Intern. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-17531-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-17531-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-17531-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T13:52:49Z","timestamp":1751205169000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-17531-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,12]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["17531"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-17531-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2018,1,12]]},"assertion":[{"value":"20 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"659"}}